Head to head
AAR Corp vs SpaceX
Side-by-side on the measures that matter, with a plain-English read. Full detail: AIR · SPCX
AIR
AAR Corp
101.84-2.99%
1-year price shape — +32% over the period
Quant Rating D · 75/100
vs
SPCX
SpaceX
127.79-7.69%
1-year price shape — not enough history yet
Quant Rating C · 0/100
1-year performance, rebased to 100
AAR Corp edges it on the scoreable measures. AAR Corp has the highest Quant Rating (75); AAR Corp earns the most per share.
| AIR | SPCX | |
|---|---|---|
| Snapshot | ||
| Sector | Aerospace & Defense | Aerospace & Defense |
| Last price | 101.84 | 127.79 |
| Change today | -2.99% | -7.69% |
| 1-year return | +31.7% | -- |
| Market cap | $4.09B | $1.74T |
| 52-week range | 77.17 – 154.00 | 104.83 – 225.64 |
| Valuation | ||
| P/E (TTM) | 20.74 | -505.10 |
| P/E percentile, own 5-yr range | 35th | 12th |
| P/B | 2.35 | 9.82 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | 4.86 | -0.38 |
| Net profit (TTM) | $195.34M | $-5.13B |
| Revenue (TTM) | $3.49B | $32.04B |
| Provider revenue period date | 2026-08-30 | 2026-09-29 |
| Revenue growth (YoY) | +24.1% | +161.4% |
| Gross margin | 19.1% | 56.7% |
| Operating margin | 8.0% | -2.0% |
| Net margin | 5.5% | -10.7% |
| Free cash flow (TTM) | $134.60M | $-40.16B |
| Provider cash-flow period date | 2026-08-30 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 102.3% | 30.3% |
| Insider activity (12mo) | 31 buy / 18 sell | 5 buy / 5 sell |
| Short interest (% of float) | 6.1% | 1.0% |
| Analyst consensus | 80% buy / 20% hold (5) | 87% buy / 10% hold / 3% sell (30) |
| Analyst price target | $150 (+47%) | $258 (+102%) |
| StockVane view | ||
| StockVane Quant Rating | D (75) | C (0) |
| Company | ||
| Employees | 7,100 | 22,000 |
| Founded | 1951 | 2002 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.